- $86.97bn
- $95.84bn
- £9.16bn
- 98
- 21
- 70
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,874 | 7,110 | 7,244 | 8,553 | 9,161 |
Cost of Revenue | |||||
Gross Profit | 5,119 | 4,623 | 4,682 | 5,508 | 5,945 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,722 | 5,455 | 5,305 | 6,239 | 6,551 |
Operating Profit | 2,152 | 1,655 | 1,939 | 2,314 | 2,610 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,847 | 1,483 | 1,797 | 2,113 | 2,295 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,515 | 1,222 | 1,471 | 1,632 | 1,788 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,505 | 1,224 | 1,471 | 1,634 | 1,781 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,505 | 1,224 | 1,471 | 1,634 | 1,781 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.786 | 0.684 | 0.75 | 0.876 | 0.988 |
Dividends per Share |